Rep. Allen: No Guarantee Pelosi's Drug Pricing Plan Would Lower Costs

Today, Congressman Rick W. Allen (GA-12) spoke on the House floor in opposition to H.R. 3, Speaker Pelosi’s radical, partisan prescription drug pricing plan. Congressman Allen’s remarks can be found below.


I rise today in opposition to Speaker Pelosi’s radical, partisan prescription drug pricing plan.

Let’s not forget that the last time Speaker Pelosi brought forward healthcare legislation it was rushed through this House and it doubled our premiums and our deductibles skyrocketed.

There is no guarantee that H.R. 3 would lower the prices of drugs, but rather it could mandate a one-size-fits-all government takeover of healthcare.

It could pose a grave threat to innovation and research and development - and ultimately patient access to life-changing prescriptions.

The bill could have far-reaching economic consequences that would negatively affect jobs, the economy and trade.

The pharmaceutical industry employs over 800,000 workers and supports an estimated 4 million jobs in this country.

I know this firsthand. Right in my district, healthcare researchers are transforming patient care and creating local jobs at the same time.

This week the House Education and Labor Committee marked-up this legislation, and unfortunately my amendment was not adopted.

My amendment would have prevented innovation and American manufacturing from moving from the United States to China.

The American people deserve for this Congress to go to work and pass legislation that is bipartisan and has a chance to become law to lower drug prices.

Stay Connected

Use the form below to sign up for my newsletter and get the latest news and updates directly to your inbox.